Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee

NCT05362851 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

692

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: YYC301-1 & YYC301-2 & YYC301-3
DRUG: YYC301 placebo & Celecoxib 200mg

Sponsor

Yooyoung Pharmaceutical Co., Ltd.

Collaborators

[object Object]